U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
TABITUXIMAB
INN  
Official Name English
OTSA-101
Preferred Name English
tabituximab [INN]
Common Name English
IMMUNOGLOBULIN G1, ANTI-(FRIZZLED RECEPTOR FRIZZLED-10) (HUMAN-MUS MUSCULUS MONOCLONAL OTSA101 HEAVY CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL OTSA101 LIGHT CHAIN, DIMER
Common Name English
Code System Code Type Description
SMS_ID
100000183541
Created by admin on Wed Apr 02 00:47:25 GMT 2025 , Edited by admin on Wed Apr 02 00:47:25 GMT 2025
PRIMARY
INN
10291
Created by admin on Wed Apr 02 00:47:25 GMT 2025 , Edited by admin on Wed Apr 02 00:47:25 GMT 2025
PRIMARY
FDA UNII
TWL5LY57R1
Created by admin on Wed Apr 02 00:47:25 GMT 2025 , Edited by admin on Wed Apr 02 00:47:25 GMT 2025
PRIMARY
CAS
1644134-10-0
Created by admin on Wed Apr 02 00:47:25 GMT 2025 , Edited by admin on Wed Apr 02 00:47:25 GMT 2025
PRIMARY
NCI_THESAURUS
C170383
Created by admin on Wed Apr 02 00:47:25 GMT 2025 , Edited by admin on Wed Apr 02 00:47:25 GMT 2025
PRIMARY
ACTIVE MOIETY
TABITUXIMAB
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966